Lorenz Studer, Memorial Sloan-Kettering Cancer Center, USA
A native of Switzerland, Lorenz Studer graduated from medical school in 1991 and received his doctoral degree in Neuroscience at the University of Bern in 1994. While there, he initiated studies leading to the first clinical trial of fetal tissue transplantation for Parkinson's disease in Switzerland. As a postdoctoral fellow he joined the laboratory of Ron McKay at the NIH in Bethesda. At the NIH he established technologies to derive midbrain dopamine neurons in vitro from dividing precursors and was first to demonstrate their successful application in animal models of Parkinson's disease.
In 2000, he moved to New York City where he started his research program at the Memorial Sloan-Kettering Cancer Center (MSKCC). Early contributions of his lab include the directed differentiation of mouse ESCs, nuclear transfer ESCs and parthenogenetic stem cells into specific neuron types. His laboratory was also first to demonstrate “therapeutic cloning” in a mouse model of a CNS disorder, and he has pioneered studies on the genetic modification, high-throughput screening and directed differentiation of human ES cells into a myriad of CNS and PNS fates. His most recent work focuses increasingly on the translational application of human pluripotent stem cells in human disease modeling, drug discovery and cell therapy.
Studer is the Director of the Sloan-Kettering Center for Stem Cell Biology. He is a Member of the Developmental Biology Program and the Department of Neurosurgery at MSKCC and a Professor in Neuroscience at Weill-Cornell.
« Go back